PRIMARY STUDY
The effect of cannabidiol (CBD) on low-frequency activity and functional connectivity in the brain of adults with and without autism spectrum disorder (ASD)
Key Findings: The results suggest that, especially in ASD, CBD alters regional fALFF and FC in/between regions consistently implicated in ASD.
Type of Study: Double Blind Clinical Trial
Study Sample Size: 34
Study Result: Positive
Study Location(s): United Kingdom
Year of Pub: 2019
Cannabinoids Studied: Cannabidiol (CBD)
Phytocannabinoid Source: Unspecified
Chemotype: Chemotype III
Sub-Ratio: 0:1 (THC:CBD)
Dosage: CBD (600 mg)